Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2RCvH1W
Πέμπτη 6 Δεκεμβρίου 2018
FDA Approves Genentech's Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer - Business Wire
FDA Approves Genentech's Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer Business Wire
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2RCvH1W
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2RCvH1W
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.